Clinical Trial: Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Breast Cancer
Study Type: INTERVENTIONAL
Official Title: A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE
Brief Summary:
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd) to standard preoperative treatment in patients with non-metastatic HER2-positive breast cancer.The main questions it aims to answer are:is T-DXd more effective than standard preoperative treatment?are there markers in the tumor or blood of patients with HER2-positive breast cancer that can help us predict response to treatment?Participants will be divided into two groups, where one group will be treated with three courses of T-DXd and the…
Read more